Table 1 Antibiotic susceptibility results for Acinetobacter Baumanni isolates
Antibiotics | Sensitive % | Intermediate % | Resistance % | |
|---|---|---|---|---|
Broad-spectrum cephalosporins | (FEP) Cephepim | 1 (1.7) | 0 (0.0) | 59 (98.3) |
(CAZ) Ceftazidime | 0 (0.0) | 0 (0.0) | 60 (100) | |
(CTX) Cefotaxime | 0 (0.0) | 0 (0.0) | 60 (100) | |
Aminoglycosides | (AN) Amikacin | 2 (3.3) | 0 (0.0) | 58 (96.7) |
(GM) Gentamicin | 3 (5.0) | 0 (0.0) | 57 (95.0) | |
Fluoroquinolones | (CIP) Ciprofloxacin | 0 (0.0) | 0 (0.0) | 60 (100) |
Polymyxins | (CL) Colistin | 58 (96.7) | 0 (0.0) | 2 (3.3) |
B-Lactam Combination Agents | (TZP) Piperacillin-tazobactam | 0 (0.0) | 0 (0.0) | 60 (100) |
(SAM) Ampicillin- sulbactam | 1 (1.7) | 0 (0.0) | 59 (98.3) | |
Folate pathway inhibitors | (SXT) Trimethoprim-sulfamethoxazole | 2 (3.3) | 0 (0.0) | 58 (96.7) |
Carbapenem | (MEM) Meropenem | 0 (0.0) | 0 (0.0) | 60 (100) |